Slide 1: 2019 First Quarter Results
2019 First Quarter Results Gentherm, Inc. April 30, 2019 Exhibit 99.2
Slide 2: Forward-Looking Statement
Forward-Looking Statement Except for historical information contained herein, statements in this presentation are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Genthe
Slide 3: Use of Non-GAAP Financial Measures
In addition to the results reported in accordance with GAAP throughout this presentation, the Company has provided information regarding “earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, transaction expenses, debt retirement expenses, impairment l
Slide 4: 1Q 2019 Highlights
Significantly outperformed the automotive market 1Q 2019 Highlights Won 2019 Automotive News Pace Award Organic revenue growth in core businesses Year-over-year Climate Control Seat (CCS®) revenue growth Continued automotive awards momentum Continued progress on Focused Growth and Margin Expansion a
Slide 5: Automotive 1Q 2019 Highlights
12 Vehicle launches with 8 OEMs Multiple CCS® product launches Hyundai Sonata Peugeot 508 Increased content in luxury vehicles Neck Conditioner for Ferrari California Heated Interior for Bentley Flying Spur Continued progress on ClimateSenseTM development and validation with multiple OEMs Leveraging
Slide 6: Automotive 1Q 2019 Awards
$400M in awards across 16 OEMs Multiple CCS® awards Hyundai CretaKia Grand Carnival Lincoln Navigator Steering Wheel Heater awards across 6 OEMs Strategic awards from Audi, BMW and Lexus Air Cooling Battery Thermal Management award from GM First BEV battery heating award leveraging proprietary techn
Slide 7: Industrial 1Q 2019 Highlights
Industrial 1Q 2019 Highlights Well positioned to grow the Medical business Double digit revenue growth in Medical sequentially and year-over-year Strong growth in Blanketrol® equipment and consumables across U.S., Latin America, and Asia Pacific Large orders from several leading U.S. hospital networ
Slide 8: Selected Income Statement Data
Selected Income Statement Data Three Months Ended March 31, 2019 2018(1) (In thousands, except per share data) Product Revenues $ 257,921 $ 264,586 Gross Margin 75,307 81,242 Gross Margin % 29% 31% Operating Expenses 53,462 60,593 Operating Income 21,845 20,649 Adjusted EBITDA 35,194 34,509 Adjusted
Slide 9: Selected Balance Sheet Data
Selected Balance Sheet Data March 31, 2019 December 31, 2018 (In thousands) Cash, Cash Equivalents and Restricted Cash $ 41,269 $ 39,620 Total Assets 763,046 803,047 Debt 100,553 139,891 Current 2,949 3,414 Non-Current 97,604 136,477 Revolving LOC Availability 261,071 221,871 Total Liquidity 302,340
Slide 10: 2019 Guidance & 2021 Outlook
2019 Guidance & 2021 Outlook 2019E 2021E Revenue Growth 4% - 6% High single-digit Organic CAGR Gross Margin 28% - 30% 30% – 32% Operating Expenses % of Revenue 19% - 20% 15% - 17% Adjusted EBITDA Margin (1) 14% - 15% High teens ROIC > 20% 2019 Guidance and 2021 Outlook Reaffirmed (1) Due to the inhe
Slide 11: Technology to the next degree
Technology to the next degree™
Slide 12: Gentherm
((l)) GENTHERM Proprietary @Gentherm 201912
Slide 13: Reconciliation of Net Income to Adjusted EBITDA
Reconciliation of Net Income to Adjusted EBITDA Three Months Ended March 31, 2019 2018(1) (In thousands) Net Income $ 8,414 $ 12,966 Add Back: Income Tax Expense 6,895 3,036 Interest Expense 1,368 1,180 Depreciation and Amortization 10,980 12,820 Adjustments: Restructuring Expenses 1,914 865 Impairm
Slide 14: Reconciliation of Adjusted EPS
Reconciliation of Adjusted EPS Three Months Ended March 31, 2019 2018(1) Diluted EPS - As Reported $ 0.25 $ 0.35 Acquisition Transaction Expenses - - Debt Retirement Expense - - Non-Cash Purchase Accounting Impacts 0.07 0.10 Unrealized Currency (Gain)/Loss (0.03) 0.10 Restructuring Expenses 0.06 0.0